Veru Inc. Files Proxy Statement Amendment
Ticker: VERU · Form: DEFA14A · Filed: May 9, 2024 · CIK: 863894
Sentiment: neutral
Topics: proxy-filing, annual-meeting, sec-filing
TL;DR
VERU proxy update filed, shareholders vote soon.
AI Summary
Veru Inc. filed a Definitive Additional Materials proxy statement on May 9, 2024. This filing relates to the company's annual meeting and is an amendment to previous filings. The company is incorporated in Wisconsin and its fiscal year ends on September 30.
Why It Matters
This filing provides shareholders with updated information regarding the company's annual meeting, which is crucial for their participation in corporate governance and voting on important matters.
Risk Assessment
Risk Level: low — This is a routine proxy filing and does not contain new material financial or operational information that would inherently increase risk.
Key Players & Entities
- VERU INC. (company) — Registrant
- 0001140361-24-025117 (filing_id) — Accession Number
- 20240509 (date) — Filing Date
- 2834 (sic_code) — Standard Industrial Classification
- FEMALE HEALTH CO (company) — Former Company Name
- WISCONSIN PHARMACAL COMPANY INC (company) — Former Company Name
FAQ
What type of filing is this for Veru Inc.?
This is a Definitive Additional Materials filing (DEFA14A) for Veru Inc.
When was this filing submitted to the SEC?
The filing was submitted on May 9, 2024.
What is Veru Inc.'s Standard Industrial Classification code?
Veru Inc.'s SIC code is 2834, which corresponds to Pharmaceutical Preparations.
What is Veru Inc.'s fiscal year end date?
Veru Inc.'s fiscal year ends on September 30.
Has Veru Inc. operated under any previous names?
Yes, Veru Inc. previously operated under the names FEMALE HEALTH CO and WISCONSIN PHARMACAL COMPANY INC.
Filing Stats: 136 words · 1 min read · ~1 pages · Grade level 12.7 · Accepted 2024-05-09 13:06:11
Filing Documents
- ny20026087x2_defa14a.htm (DEFA14A) — 20KB
- ny20026087x2_nc01.jpg (GRAPHIC) — 1523KB
- ny20026087x2_nc02.jpg (GRAPHIC) — 1132KB
- 0001140361-24-025117.txt ( ) — 3679KB
From the Filing
14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. 1) Filed by the Registrant Filed by a Party other than the Registrant Check the appropriate box: Preliminary Proxy Statement Confidential, for use of the Commission only (as permitted by Rule 14a-6(e)(2)) Definitive Proxy Statement Definitive Additional Materials Soliciting Material under Section 240.14a-12 VERU INC. (Name of Registrant as Specified in Its Charter) (Name of Person(s) Filing Proxy Statement, if Other Than the Registrant) Payment of filing fee (Check all boxes that apply): No fee required. Fee paid previously with preliminary materials. Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.